Q1. How many patients have been treated for severe asthma (ICD10 code J45.5) in the last three months?
a. Total patients
b. Patients aged 6-11 years
c. Patients aged 12-17 years
d. Patients aged 18 years and above
Q2. How many patients have been treated (for any condition) in the last three months with:
a. Benralizumab
b. Omalizumab
c. Reslizumab
d. Mepolizumab
Q3. How many patients have been treated in the last three months for asthma ONLY with:
a. Dupilumab
b. Upadacitinib